212 related articles for article (PubMed ID: 10374691)
21. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
[TBL] [Abstract][Full Text] [Related]
22. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
23. Telomerase activity during carcinogenesis in the bronchus.
Kakihana M; Yahata N; Hirano T; Honda H; Ikeda N; Kawate N; Konaka C; Ebihara Y; Ohyashiki K; Kato H
Oncol Rep; 2002; 9(1):43-9. PubMed ID: 11748453
[TBL] [Abstract][Full Text] [Related]
24. [Detection of human telomerase activity by telomerase TRAP-ELISA assay].
Wei L; Guo Y; Yan Z
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):264-6. PubMed ID: 10920979
[TBL] [Abstract][Full Text] [Related]
25. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
26. Telomerase activation in colorectal carcinogenesis.
Yan P; Saraga EP; Bouzourene H; Bosman FT; Benhattar J
J Pathol; 1999 Oct; 189(2):207-12. PubMed ID: 10547576
[TBL] [Abstract][Full Text] [Related]
27. Telomerase activity and homozygous deletions of the p16 gene in liver metastases of colorectal carcinoma.
Ma J; Zhan W; Peng J; He Y; Zheng Z; Cai S; Wang L; Wang J
Chin Med J (Engl); 2001 Oct; 114(10):1068-72. PubMed ID: 11677769
[TBL] [Abstract][Full Text] [Related]
28. [Quantitative detection of telomerase activity and its association with clinicopathological characteristics in breast cancer].
He GP; Shui QL; Huang Y; Zhang SZ; Yu H
Ai Zheng; 2004 Sep; 23(9):1041-6. PubMed ID: 15363198
[TBL] [Abstract][Full Text] [Related]
29. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
30. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
[TBL] [Abstract][Full Text] [Related]
31. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions.
Tahara H; Kuniyasu H; Yokozaki H; Yasui W; Shay JW; Ide T; Tahara E
Clin Cancer Res; 1995 Nov; 1(11):1245-51. PubMed ID: 9815918
[TBL] [Abstract][Full Text] [Related]
32. Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.
Jernvall P; Mäkinen MJ; Karttunen TJ; Mäkelä J; Vihko P
Br J Cancer; 1999 Feb; 79(5-6):903-8. PubMed ID: 10070888
[TBL] [Abstract][Full Text] [Related]
33. Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients.
Shim WY; Park KH; Jeung HC; Kim YT; Kim TS; Hyung WJ; An SH; Yang SH; Noh SH; Chung HC; Rha SY
Int J Mol Med; 2005 Nov; 16(5):857-63. PubMed ID: 16211255
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of telomerase in the development and progression of colon cancer.
Boldrini L; Faviana P; Gisfredi S; Zucconi Y; Di Quirico D; Donati V; Berti P; Spisni R; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
Int J Mol Med; 2002 Nov; 10(5):589-92. PubMed ID: 12373297
[TBL] [Abstract][Full Text] [Related]
35. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Lam AK; Ong K; Ho YH
Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
[TBL] [Abstract][Full Text] [Related]
36. Quantitative analysis of survivin in colorectal adenocarcinoma: increased expression and correlation with telomerase activity.
Lam AK; Saleh S; Smith RA; Ho YH
Hum Pathol; 2008 Aug; 39(8):1229-33. PubMed ID: 18547619
[TBL] [Abstract][Full Text] [Related]
37. hTERT expression in sporadic renal cell carcinomas.
Paradis V; Bièche I; Dargère D; Bonvoust F; Ferlicot S; Olivi M; Lagha NB; Blanchet P; Benoît G; Vidaud M; Bedossa P
J Pathol; 2001 Sep; 195(2):209-17. PubMed ID: 11592100
[TBL] [Abstract][Full Text] [Related]
38. [Detection of telomerase activity in bronchoscopic brush-off samples in patients with lung cancer].
Yan YL; Zheng JX; Wang X; Wang Y; Yang JY
Ai Zheng; 2002 Jul; 21(7):768-71. PubMed ID: 12479104
[TBL] [Abstract][Full Text] [Related]
39. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.
Herbert BS; Hochreiter AE; Wright WE; Shay JW
Nat Protoc; 2006; 1(3):1583-90. PubMed ID: 17406450
[TBL] [Abstract][Full Text] [Related]
40. Determining the telomerase activity of exfoliated cells in intestinal lavage solution to detect colorectal carcinoma.
Ishibashi K; Hirose K; Kato H; Ogawa K; Haga S
Anticancer Res; 1999; 19(4B):2831-6. PubMed ID: 10652561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
